Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis
B Wei, R Zhang, H Zeng, L Wu, R He… - Expert Review of Anti …, 2023 - Taylor & Francis
Background We aimed to assess the impact of antiviral drugs (fluvoxamine, remdesivir,
lopinavir/ritonavir (LPV/r), molnupiravir, andnirmatrelvir/ritonavir (NRV/r)) on health care …
lopinavir/ritonavir (LPV/r), molnupiravir, andnirmatrelvir/ritonavir (NRV/r)) on health care …
Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence
I Karniadakis, N Mazonakis, C Tsioutis… - Infectious Disease …, 2023 - mdpi.com
Vaccines remain the cornerstone of medical prevention and are highly effective in reducing
the risk of severe disease and death due to coronavirus disease 2019 (COVID-19). In the …
the risk of severe disease and death due to coronavirus disease 2019 (COVID-19). In the …
Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19
The aim of this study was to investigate the clinical efficacy of a combination of nirmatrelvir
and ritonavir (NMV‐r) for treating COVID‐19 in patients with diabetes mellitus (DM). This …
and ritonavir (NMV‐r) for treating COVID‐19 in patients with diabetes mellitus (DM). This …
SARS-CoV-2 genomics and impact on clinical care for COVID-19
R Lorenzo-Redondo… - Journal of …, 2023 - academic.oup.com
The emergence and worldwide spread of SARS-CoV-2 during the COVID-19 pandemic
necessitated the adaptation and rapid deployment of viral WGS and analysis techniques that …
necessitated the adaptation and rapid deployment of viral WGS and analysis techniques that …
Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the American College of Physicians (Version 2)
Background: Clinicians and patients want to know the benefits and harms of outpatient
treatment options for the Omicron variant of SARS-CoV-2. Purpose: To assess the benefits …
treatment options for the Omicron variant of SARS-CoV-2. Purpose: To assess the benefits …
Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients
Background The outcomes of older adult people acquiring SARS-CoV-2 reinfection was
unclear. This study aimed to compare the outcomes of older adult patients with COVID-19 …
unclear. This study aimed to compare the outcomes of older adult patients with COVID-19 …
Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID‐19: A systematic review and meta‐analysis
Abstract Background and Aim This systematic review and meta‐analysis aimed to compare
the effectiveness and safety of molnupiravir and sotrovimab in the treatment of patients with …
the effectiveness and safety of molnupiravir and sotrovimab in the treatment of patients with …
[HTML][HTML] The effect of oral antiviral therapy for COVID-19 in managing non-hospitalized patients with lung cancer
Backgrounds The effectiveness of oral antiviral therapy including nirmatrelvir plus ritonavir
and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer …
and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer …
Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis
Background The majority of available data on molnupiravir come from an unvaccinated
COVID-19 population. Therefore, we conducted this meta-analysis to integrate evidence …
COVID-19 population. Therefore, we conducted this meta-analysis to integrate evidence …
Response to the letter to the editor on" Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review …
Response to the letter to the editor on "Clinical efficacy and safety of molnupiravir for
nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis …
nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis …